SINGH BIOTECHNOLOGY LLC has a total of 35 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ECS PROGASTRIN SA, SINGH MOLECULAR MEDICINE LLC and CHIN LI-TE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | China | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Republic of Korea | 3 | |
#5 | Russian Federation | 3 | |
#6 | Argentina | 2 | |
#7 | Brazil | 2 | |
#8 | Canada | 2 | |
#9 | Israel | 2 | |
#10 | Japan | 2 | |
#11 | Mexico | 2 | |
#12 | WIPO (World Intellectual Property Organization) | 2 | |
#13 | Australia | 1 | |
#14 | Serbia | 1 | |
#15 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Singh Sunanda | 25 |
#2 | Sunanda Singh | 7 |
#3 | Sunanda Dr Singh | 1 |
Publication | Filing date | Title |
---|---|---|
US2018072815A1 | Single Domain Antibodies Directed Against Intracellular Antigens | |
TW201716434A | Single domain antibodies directed against intracellular antigens |